Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

Overview of attention for article published in Investigational New Drugs, September 2010

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo... http://t.co/0DlmpnnH PM

Reply Repost Favourite